Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients

被引:44
|
作者
Sharma, S
Driscoll, D
Odunsi, K
Venkatadri, A
Lele, S
机构
[1] SUNY Buffalo, Grad Sch, Roswell Pk Canc Inst, Div Gynecol Oncol,Dept Surg, Buffalo, NY USA
[2] SUNY Buffalo, Grad Sch, Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY USA
关键词
ovarian cancer; elderly; poor surgical candidates; complications; debulking; cytoreduction;
D O I
10.1016/j.ajog.2005.06.074
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Surgery is the cornerstone of management in ovarian cancer. However, in high-risk and elderly patients there is a tendency for less aggressive surgery upfront. The aim of this study was to review cytoreductive surgery, with focus on complications and outcomes in patients with Multiple Surgical risk factors. Study design: Charts of patients with ovarian cancer from 1998 to 2002 were retrospectively reviewed. Results: One hundred and forty patients were treated for ovarian cancer. Sixty-three patients (45%) were elderly (>= 65 years), and 69 patients (49%) had comorbidities. Optimal debulking (< 1 cm) was achieved in 123 patients (88%). There was no significant relation between complications and type of procedure, elderly age, comorbidities, or transfusions. Optimally debulked patients had a significantly longer survival than patients with suboptimal debulking (P < .001). Conclusion: Aggressive optimal cytoreduction can be achieved in the majority of patients with multiple surgical risk factors and is associated with a low complication rate. (c) 2005 Mosby, Inc. All rights reserved.
引用
收藏
页码:2077 / 2082
页数:6
相关论文
共 50 条
  • [31] High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population
    Ingerslev, Kasper
    Hogdall, Estrid
    Skovrider-Ruminski, Wojciech
    Schnack, Tine Henrichsen
    Karlsen, Mona Aarenstrup
    Nedergaard, Lotte
    Hogdall, Claus
    Blaakaer, Jan
    INFECTIOUS AGENTS AND CANCER, 2016, 11
  • [32] Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints
    Paolo Sammartino
    Tommaso Cornali
    Marialuisa Framarino dei Malatesta
    Pompiliu Piso
    World Journal of Obstetrics and Gynecology, 2013, (04) : 101 - 107
  • [33] Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer-is interval cytoreductive surgery still needed?
    Klein, David A.
    Mann, Amandeep K.
    Freeman, Alexandra H.
    Liao, Cheng-I
    Kapp, Daniel S.
    Chan, John K.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (02)
  • [34] Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
    Solmaz, Ulas
    Mat, Emre
    Dereli, Murat Levent
    Turan, Volkan
    Peker, Nuri
    Tosun, Gokhan
    Dogan, Askin
    Adiyeke, Mehmet
    Ozdemir, Aykut
    Gungorduk, Kemal
    Sanci, Muzaffer
    Yildirim, Yusuf
    JOURNAL OF BUON, 2015, 20 (02): : 580 - 587
  • [35] Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
    Solmaz, Ulas
    Mat, Emre
    Dereli, Murat Levent
    Turan, Volkan
    Peker, Nuri
    Tosun, Gokhan
    Dogan, Askin
    Adiyeke, Mehmet
    Ozdemir, Aykut
    Gungorduk, Kemal
    Sanci, Muzaffer
    Yildirim, Yusuf
    JOURNAL OF BUON, 2015, 20 (03): : 847 - 854
  • [36] Surgery for elderly patients with ovarian cancer
    Martin G. A. Bäuerle
    Rolf Kreienberg
    Tanja Volm
    Current Oncology Reports, 2003, 5 (6) : 482 - 485
  • [37] Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry
    Chambers, Laura M.
    Yao, Meng
    Morton, Molly
    Chichura, Anna
    Costales, Anthony B.
    Horowitz, Max
    Gruner, Morgan F.
    Rose, Peter G.
    Michener, Chad M.
    DeBernardo, Robert
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (07) : 1021 - 1030
  • [38] Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
    Ansaloni, Luca
    Agnoletti, Vanni
    Amadori, Andrea
    Catena, Fausto
    Cavaliere, Davide
    Coccolini, Federico
    De Iaco, Pierandrea
    Di Battista, Monica
    Framarini, Massimo
    Gazzotti, Filippo
    Ghermandi, Claudio
    Kopf, Barbara
    Saponara, Maristella
    Tauceri, Francesca
    Vallicelli, Carlo
    Verdecchia, Giorgio Maria
    Pinna, Antonio Daniele
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 778 - 785
  • [39] Cytoreductive surgery and HIPEC after neoadjuvant chemotherapy for advanced epithelial ovarian cancer
    Marco Lotti
    Luisa Maria Busci
    Luca Campanati
    Fausto Catena
    Federico Coccolini
    Naoual Bakrin
    Pierandrea De Iaco
    Giorgio Ercolani
    Giuseppe Grosso
    Michele Pisano
    Elia Poiasina
    Diego Rossetti
    Martina Rossi
    Claudio Zamagni
    Paolo Bertoli
    Antonio Daniele Pinna
    Luigi Frigerio
    Luca Ansaloni
    World Journal of Obstetrics and Gynecology, 2013, (04) : 167 - 175
  • [40] Benefit of Negative Pressure Drain Within Surgical Wound After Cytoreductive Surgery for Ovarian Cancer
    Kim, Se Ik
    Lim, Myong Cheol
    Bae, Hyo Sook
    Shin, Se Ra
    Seo, Sang-Soo
    Kang, Sokbom
    Park, Sang-Yoon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (01) : 145 - 151